Eugenix Hair Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 33.73%
(FY 2023)
- Profit -9.23%
(FY 2023)
- Ebitda -4.37%
(FY 2023)
- Net Worth 51.87%
(FY 2023)
- Total Assets 45.96%
(FY 2023)
About Eugenix Hair Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Arika Bansal and Pradeep Sethi serve as directors at the Company.
- CIN/LLPIN
U73200HR2014PTC053385
- Company No.
053385
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Sep 2014
- Date of AGM
30 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Eugenix Hair Sciences Private Limited offer?
Eugenix Hair Sciences Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Hair Treatment.
Who are the key members and board of directors at Eugenix Hair Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arika Bansal  | Director | 15-Sep-2014 | Current |
| Pradeep Sethi | Director | 05-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Eugenix Hair Sciences.
Eugenix Hair Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.73% increase. The company also saw a slight decrease in profitability, with a 9.23% decrease in profit. The company's net worth Soared by an impressive increase of 51.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eugenix Hair Sciences?
In 2023, Eugenix Hair Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eugenix Biotech Private LimitedActive 10 years 2 monthsArika Bansal and Pradeep Sethi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eugenix Hair Sciences?
Eugenix Hair Sciences has a workforce of 90 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eugenix Hair Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugenix Hair Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
